You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 31 No. 6, December 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Muscle in Lafora Disease

Diana L. Coleman, MS; Pierluigi Gambetti, MD; Salvatore Di Mauro, MD; Robert E. Blume, MD

Arch Neurol. 1974;31(6):396-406.


Abstract

Ultrastructural studies of muscle from a patient with Lafora disease showed sheets of glycogen particles and fine granular-filamentous material between myofibrils. These structures were frequently intermingled and stained intensely with silver proteinate, a specific stain for polysaccharides. Methods for isolation of glycogen yielded excessive hexose-releasing material. In chromatographic analysis of a hydrolysate of this material, glucose was the only component sugar. Compared with action on normal muscle glycogen, phosphorylase was ineffective, β-amylase 50% less effective, but {alpha}-amylase normally effective in degrading the Lafora polyglucosan. Incubation of muscle homogenate or isolated polyglucosan with a mixture of glucosidases capable of completely degrading normal glycogen (Diazyme) resulted in only 30% digestion of the Lafora polyglucosan. The metabolic error causing the accumulation of anomalous polysaccharide in this generalized storage disease remainsobscure.



Author Affiliations

From the Department of Biochemistry, Division of Neuropathology, and the Department of Neurology, University of Pennsylvania, Philadelphia (Ms. Coleman, Drs. Gambetti and Di Mauro), and the Department of Neurology, Mercy Hospital, Pittsburgh (Dr. Blume). Part of this work was submitted by Diana L. Coleman in partial fulfillment for the degree of Master of Science.


Footnotes

Accepted for publication April 5, 1974.

Read in part at the 49th annual meeting of the American Association of Neuropathologists, Freeport, Grand Bahama, June 16, 1973.

Reprint requests to Columbia University College of Physicians & Surgeons, 710 W 168th St, New York, NY 10032 (Dr. Di Mauro).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Laforin, a Dual Specificity Phosphatase That Dephosphorylates Complex Carbohydrates
Worby et al.
J. Biol. Chem. 2006;281:30412-30418.
ABSTRACT | FULL TEXT  

Lafora's Disease: Comparison of Inclusion Bodies in Skin and in Brain
Busard et al.
Arch Neurol 1986;43:296-299.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.